Dr.  Vicente Soriano, MD, PhD - UNIR Health Sciences School - Professor

Dr. Vicente Soriano

MD, PhD

UNIR Health Sciences School

Professor

Madrid, Madrid | Spain

Main Specialties: Hepatology, Infectious Disease, Medical Genetics

Additional Specialties: Infectious Diseases

ORCID logohttps://orcid.org/0000-0002-4624-5199


Top Author

Dr.  Vicente Soriano, MD, PhD - UNIR Health Sciences School - Professor

Dr. Vicente Soriano

MD, PhD

Introduction

Vicente Soriano, MD, PhD, received his medical degree in Barcelona, Spain, where he subsequently conducted his specialty training on internal medicine. After completing a post-doctoral stage at the CBER, FDA in Bethesda (USA), he returned to Spain and joined the Department of Infectious Diseases at Hospital Carlos III in Madrid. He became the assistant director since 1999. His expertise has focused mainly on viral infections, specifically HIV and viral hepatitis. More recently his area of interest expand to human genomics.
Dr. Soriano is the editor-in-chief of AIDS Reviews, an international, peer-reviewed journal focused on HIV research (impact factor ?4). His team has produced more than 900 publications in international journals (PubMed) and currently is ranked within the first 10 worldwide in terms of impact factor in scientific publications in the field of HIV infection (www.aidshivresearch.com).
Chair of the International Hepatitis & HIV Coinfection Panel, Dr. Soriano is assisting the National AIDS Program in Spain and is the editor of Manual del SIDA, a reference textbook of HIV/AIDS for Spanish-speaking countries. He has been advisor for WHO and the European Commission. More recently he became professor at the UNIR Health Sciences School.

Primary Affiliation: UNIR Health Sciences School - Madrid, Madrid , Spain

Specialties:

Additional Specialties:

Research Interests:


View Dr. Vicente Soriano’s Resume / CV

Education

Nov 1992
CBER, FDA, Bethesda
Post-doc
Virology
Sep 1980 - Jan 1986
Medical School, Autonomous University
Professor
Infectious Diseases
Sep 1980 - Jan 1986
Medical School, Autonomous University Barcelona
Professor
Infectious Diseases

Experience

Jan 2018 - Jan 2018
UNIR-Madrid, Universidad Internacional de La Rioja
Professor
Facultad Ciencias de la Salud
Apr 2015 - May 2014
Hospital Universitario La Paz, Madrid
Consultant
Infectious Diseases
Apr 2015 - Jun 1992
Hospital Carlos III, Madrid
Assistant Director
Infectious Diseases
Jan 2018
Universidad Internacional de La Rioja
Apr 2015
Hospital Universitario La Paz
Consultant
Infectious Diseases

Publications

1239Publications

1893Reads

618Profile Views

324PubMed Central Citations

Hot News: HTLV-1 Infection Still A Neglected Disease

Authors:
Vicente Soriano

AIDS Rev 2018;20(3):175

UNIR Health Sciences School and La Paz University Hospital Madrid, Spain.

View Article

Download full-text PDF

Source
February 2019
6 Reads

Hot News: Hepatitis B Gene Therapy Coming to Age.

Authors:
Vicente Soriano

AIDS Rev 2018 Apr-Jun;20(2):125-127

La Paz University Hospital and UNIR Health Sciences School, Madrid, Spain.

View Article

Download full-text PDF

Source
October 2018
21 Reads
3.790 Impact Factor

Report from the International Conference on Viral Hepatitis - 2017.

AIDS Rev 2018 Jan-Mar;20(1):58-70

Liver Unit, Rush University Medical Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
October 2018
8 Reads
3.790 Impact Factor

Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.

Eur J Gastroenterol Hepatol 2018 09;30(9):1060-1062

Infectious Diseases Unit, La Paz University Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000001163DOI Listing
September 2018
11 Reads
2.152 Impact Factor

Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C.

Antivir Ther 2017 15;22(7):571-575. Epub 2017 Feb 15.

Department of Internal Medicine & Liver Transplantation Unit, Puerta de Hierro Research Institute & University Hospital, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3138DOI Listing
July 2018
9 Reads
2 Citations
3.020 Impact Factor

Hot News: Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.

Authors:
Vicente Soriano

AIDS Rev 2017 Oct-Dec;19(3):167-172

Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
June 2018
70 Reads
3.790 Impact Factor

Treatment and prevention of HIV infection with long-acting antiretrovirals.

Expert Rev Clin Pharmacol 2018 May 29;11(5):507-517. Epub 2018 Mar 29.

b Laboratory of Internal Medicine , Puerta de Hierro Research Institute , Majadahonda , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2018.1453805DOI Listing
May 2018
15 Reads

Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials.

Antivir Ther 2017 24;22(4):307-312. Epub 2016 Jun 24.

Department of Internal Medicine, Puerta de Hierro Research Institute & University Hospital, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3061DOI Listing
May 2018
44 Reads
7 Citations
3.020 Impact Factor

AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.

Viruses 2018 05 30;10(6). Epub 2018 May 30.

Department of Infectious Diseases, University Hospital Crosshouse, Kilmarnock KA2 0BE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/v10060293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024378PMC
May 2018
8 Reads
1 Citation
3.280 Impact Factor

Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.

Cancer 2018 Apr 27;124(8):1647-1649. Epub 2018 Feb 27.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31291DOI Listing
April 2018
4 Reads
1 Citation
4.890 Impact Factor

A New HIV Paradigm: Dual Antiretroviral Regimens as Maintenance Therapy.

AIDS Rev 2017 Apr - Jun;19(2):113-114

La Paz University Hospital, Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
February 2018
8 Reads
1 Citation
3.790 Impact Factor

Hepatitis A Outbreaks in European Homosexual Men.

AIDS Rev 2017 Apr - Jun;19(2):113-114

La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
February 2018
14 Reads
1 Citation
3.790 Impact Factor

Should HIV Patients be concerned about Occult Hepatitis B?

AIDS Rev 2018;20(4):238-239

UNIR Health Sciences School and La Paz University Hospital Madrid, Spain.

View Article

Download full-text PDF

Source
January 2018

High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy.

Antivir Ther 2016 18;21(6):489-494. Epub 2016 Feb 18.

Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3038DOI Listing
January 2018
9 Reads
2 Citations
3.020 Impact Factor

Decline and changing profile of hepatitis delta among injection drug users in Spain.

Antivir Ther 2018 ;23(1):87-90

Infectious Diseases Unit, La Paz University Hospital & Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3161DOI Listing
January 2018
50 Reads
3.020 Impact Factor

Hepatitis Delta Could Be More Frequent than Previously Thought.

AIDS Rev 2018;20(4):236

UNIR Health Sciences School and La Paz University Hospital Madrid, Spain.

View Article

Download full-text PDF

Source
January 2018

Is Ribavirin Teratogenic in Humans? No Evidence So Far.

Drug Saf 2017 12;40(12):1163-1165

Infectious Diseases Unit, La Paz University Hospital and Medical School, Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40264-017-0597-zDOI Listing
December 2017
10 Reads
2.824 Impact Factor

Need to Face Liver Cirrhosis after HCV Cure with Antivirals.

EBioMedicine 2017 10 25;24:24-25. Epub 2017 Aug 25.

Liver Transplantation Unit, Internal Medicine Department, Puerta de Hierro Research Institute, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2017.08.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651974PMC
October 2017
12 Reads
1 Citation

Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C.

Expert Opin Drug Metab Toxicol 2017 Sep 28;13(9):1015-1022. Epub 2017 Jul 28.

b Department of Internal Medicine , Puerta de Hierro Research Institute , Majadahonda , Spain.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17425255.2017.1
Publisher Site
http://dx.doi.org/10.1080/17425255.2017.1359254DOI Listing
September 2017
73 Reads
2 Citations
2.831 Impact Factor

Dual antiretroviral therapy for HIV infection.

Expert Opin Drug Saf 2017 Aug 11;16(8):923-932. Epub 2017 Jul 11.

d Internal Medicine Department , Nuestra Señora de la Paz Hospital , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1343300DOI Listing
August 2017
10 Reads
1 Citation
2.911 Impact Factor

Drug interactions in HIV-infected patients treated for hepatitis C.

Expert Opin Drug Metab Toxicol 2017 Aug 13;13(8):807-816. Epub 2017 Jul 13.

a Infectious Diseases Unit , La Paz University Hospital , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2017.1351942DOI Listing
August 2017
12 Reads
1 Citation
2.831 Impact Factor

Obituary: HIV/AIDS researcher Mark Wainberg passed away.

AIDS Rev 2017 Apr - Jun;19(2):115

Infectious Diseases Department, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
July 2017
6 Reads
3.790 Impact Factor

Human T-lymphotropic virus type 1 infection and disease in Spain.

AIDS 2017 07;31(12):1653-1663

aPuerta de Hierro Research Institute, Majadahonda, Madrid bHospital Vall d'Hebrón, Barcelona cHospital de Conxo-CHUS, Santiago de Compostela dClinic University Hospital, Valladolid eBlood and Tissue Bank, Barcelona fRegional Transfusion Center, Madrid gCentro de Hemoterapia de Castilla-León, Valladolid hHospital Miguel Servet, Zaragoza iHospital Clínico Universitario Lozano Blesa, Zaragoza jUniversity Clinic kComplejo Hospitalario, Pamplona lCentro Sanitario Sandoval, Madrid mCristal-Piñor Hospital, Orense nGeneral Hospital, Alicante oHospital Virgen del Rocío, CIBERESP, Seville pRio Ortega Hospital, Valladolid qLa Paz University Hospital, Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001527DOI Listing
July 2017
78 Reads
5.554 Impact Factor

Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response.

J Antimicrob Chemother 2017 07;72(7):2083-2088

Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkx090DOI Listing
July 2017
10 Reads
1 Citation
5.313 Impact Factor

HIV type 2 epidemic in Spain: challenges and missing opportunities.

AIDS 2017 06;31(10):1353-1364

aPuerta de Hierro Research Institute, Madrid bHospital de Poniente, Almeria cHospital Vall d'Hebrón, Barcelona dCorporación Sanitaria Parc Taulí, Sabadell eSon Espases Hospital, Palma de Mallorca fHospital Marqués de Valdecilla, Santander gFundación Jiménez Díaz, Madrid hGeneral Hospital, Alicante iLa Paz University Hospital & Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001485DOI Listing
June 2017
60 Reads
2 Citations
5.554 Impact Factor

Transmission of Multi-Drug Resistant HIV-1 Despite Antiretroviral Prophylaxis.

Authors:
Vicente Soriano

AIDS Rev 2017 Jan-Mar;19(1):54-55

La Paz University Hospital, Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
March 2017
9 Reads
1 Citation
3.790 Impact Factor

Reactivation of Hepatitis B in HIV Patients Treated for Hepatitis C.

Authors:
Vicente Soriano

AIDS Rev 2016 Oct-Dec;18(4):222-223

Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
January 2017
12 Reads
1 Citation
3.790 Impact Factor

Hepatitis C virus resistance to the new direct-acting antivirals.

Expert Opin Drug Metab Toxicol 2016 Oct 18;12(10):1197-209. Epub 2016 Jul 18.

a Infectious Diseases Unit , IdiPAZ & La Paz University Hospital , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2016.1209484DOI Listing
October 2016
10 Reads
8 Citations
2.831 Impact Factor

The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain.

AIDS Rev 2015 Oct-Dec;17(4):212-9

Infectious Diseases Unit, La Paz University Hospital IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
September 2016
7 Reads
2 Citations
3.790 Impact Factor

IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.

Liver Int 2016 09 14;36(9):1258-66. Epub 2016 Mar 14.

Unidad de Infección viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13079DOI Listing
September 2016
22 Reads
1 Citation
4.850 Impact Factor

Non-Human Cancers in AIDS Patients.

AIDS Rev 2015 Oct-Dec;17(4):238-9

Infectious Diseases Unit. La Paz University Hospital. Madrid, Spain.

View Article

Download full-text PDF

Source
September 2016
12 Reads
3.790 Impact Factor

Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.

Eur J Gastroenterol Hepatol 2016 Aug;28(8):923-6

aJ.W. Goethe University Hospital, Frankfurt am Main bBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach cBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany dThe Liver Institute at Methodist Dallas Medical Center, Dallas eCentral Texas Clinical Research, Austin, Texas fNorthwest Indiana Center for Clinical Research, Valparaiso, Indiana gScripps Clinic, La Jolla, California hBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA iHospital Carlos III, Madrid jHospital Universitario Valle de Hebrón and CIBERehd del Instituto Carlos III, Barcelona, Spain kUniversity Clinic for Visceral Surgery and Medicine, University of Bern, Bern, Switzerland lAustin Health, Heidelberg, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000649DOI Listing
August 2016
16 Reads
2.152 Impact Factor

Is HIV still a special population for the treatment of hepatitis C?

AIDS 2016 07;30(12):2001-3

aDepartment of Medicine, Division of Infectious Diseases, Owen Clinic, University of California at San Diego, San Diego, California, USA bInfectious Diseases Unit, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955702PMC
July 2016
6 Reads
2 Citations
5.554 Impact Factor

SOLAR-2: the sun also rises for cirrhotics.

Lancet Infect Dis 2016 06 18;16(6):624-625. Epub 2016 Feb 18.

Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(16)00079-7DOI Listing
June 2016
6 Reads
1 Citation
22.433 Impact Factor

Prevention and management of treatment failure to new oral hepatitis C drugs.

Expert Opin Pharmacother 2016 Jun 9;17(9):1215-23. Epub 2016 May 9.

b Infectious Diseases Unit , La Paz University Hospital , Madrid , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2016.1182156DOI Listing
June 2016
23 Reads
7 Citations
3.534 Impact Factor

Hypoglycemia in a diabetic patient during hepatitis C therapy.

Hepatology 2016 06 26;63(6):2065-6. Epub 2015 Nov 26.

Department of Internal Medicine, Puerta de Hierro Research Institute, Majadahonda, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28137DOI Listing
June 2016
7 Reads
2 Citations
11.055 Impact Factor

Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.

Expert Opin Drug Saf 2015 28;14(9):1421-34. Epub 2015 Jul 28.

a 1 La Paz University Hospital, Infectious Diseases Unit , Madrid, Spain +34 91 7277000 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2015.1073258DOI Listing
May 2016
7 Reads
3 Citations
2.911 Impact Factor

Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy.

AIDS Res Hum Retroviruses 2016 Mar 1;32(3):226-31. Epub 2015 Dec 1.

2 Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III , Majadahonda, Madrid, Spain .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2015.0223DOI Listing
March 2016
11 Reads
2.330 Impact Factor

Caution with new oral hepatitis C drugs.

AIDS Rev 2015 Apr-Jun;17(2):121-2

La Paz University Hospital & IdiPAZ, Madrid, Spain.

View Article

Download full-text PDF

Source
February 2016
4 Reads
3.790 Impact Factor

Prioritization of new oral hepatitis C therapies for HIV patients.

AIDS Rev 2015 Jan-Mar;17(1):65-7

La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
November 2015
3 Reads

Rate and predictors of serum HCV-RNA >6 million IU/mL in patients with chronic hepatitis C.

J Clin Virol 2015 Oct 13;71:63-6. Epub 2015 Aug 13.

Infectious Diseases Unit, La Paz University Hospital, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2015.08.001DOI Listing
October 2015
24 Reads
3.020 Impact Factor

Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients.

Curr Opin HIV AIDS 2015 Sep;10(5):309-15

aHospital Universitario La Paz bInstituto de Investigación Sanitaria La Paz cHospital General Universitario Gregorio Marañón dInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-hivandaids/2015/09000/Extrah
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/COH.0000000000000175DOI Listing
September 2015
7 Reads
9 Citations
4.680 Impact Factor

RNA viruses at the forefront of human infections - HIV, hepatitis C, and now Ebola.

AIDS Rev 2014 Oct-Dec;16(4):246-7

Infectious Diseases Unit, La Paz Hospital & Autonomous University, Madrid, Spain.

View Article

Download full-text PDF

Source
August 2015
4 Reads
3.790 Impact Factor

TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients.

J Clin Virol 2015 Apr 9;65:62-7. Epub 2015 Feb 9.

Unidad de Infección viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2015.02.004DOI Listing
April 2015
17 Reads
1 Citation
3.020 Impact Factor

Update of the DHHS antiretroviral treatment guidelines.

Authors:
Vincent Soriano

AIDS Rev 2014 Apr-Jun;16(2):117-8

Internal Medicine & Infectious Diseases, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
April 2015
7 Reads

HIV-2 and HTLV-1 infections in Spain, a non-endemic region.

AIDS Rev 2014 Jul-Sep;16(3):152-9

Department of Infectious Diseases, Hospital Carlos III, Madrid; Department of Internal Medicine, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
March 2015
22 Reads
1 Citation
3.790 Impact Factor

Gene therapy for HIV infection.

Expert Opin Biol Ther 2015 Mar 17;15(3):319-27. Epub 2014 Oct 17.

Puerta de Hierro Research Institute and University Hospital, Department of Internal Medicine , Majadahonda, Madrid , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2015.967208DOI Listing
March 2015
10 Reads
2 Citations
3.743 Impact Factor

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.

AIDS 2015 Mar;29(5):571-81

aIcahn School of Medicine at Mount Sinai, New York, USA bChelsea and Westminster Hospital, London, UK cHospital Carlos III, Madrid, Spain dEPIMED, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany eHospital de la Santa Creu i Sant Pau, Barcelona, Spain fUniversity of Bonn, Bonn, Germany gRoyal Free Hospital, London, UK hHospital Clínic iHospital Universitari Germans Trias i Pujol and Universitat Autònoma de Barcelona, Barcelona, Spain jMedizinisches Infektiologiezentrum Berlin (MIB), Berlin, Germany kUT Southwestern Medical Center, Dallas, Texas lBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA mBoehringer Ingelheim España S.A., Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000579DOI Listing
March 2015
14 Reads
3 Citations
5.554 Impact Factor

Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study.

Liver Int 2015 Feb 16;35(2):417-21. Epub 2014 Oct 16.

J. W. Goethe University Hospital, Frankfurt am Main, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12693DOI Listing
February 2015
16 Reads
6 Citations
4.850 Impact Factor

Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.

Expert Opin Pharmacother 2015 Feb 22;16(2):179-86. Epub 2014 Dec 22.

Department of Internal Medicine and Infectious Diseases , La Paz University Hospital , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.973852DOI Listing
February 2015
8 Reads
1 Citation
3.534 Impact Factor

PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy.

J Acquir Immune Defic Syndr 2014 Oct;67(2):113-9

*Unidad de Infección viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain; †Unidad de Enfermedades Infecciosas/VIH; Hospital General Universitario "Gregorio Marañón," Madrid, Spain; ‡Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; §IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid Spain; and ‖Servicio de Enfermedades Infecciosas, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000282DOI Listing
October 2014
43 Reads
2 Citations
4.560 Impact Factor

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.

J Antimicrob Chemother 2014 Aug 30;69(8):2191-4. Epub 2014 Apr 30.

Hospital Carlos III, Madrid, Spain Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dku119DOI Listing
August 2014
42 Reads
5.313 Impact Factor

X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain.

AIDS 2014 Jul;28(11):1603-9

aHospital Carlos III bCentro Sanitario Sandoval, Madrid cHospital Conxo-CHUS, Santiago dHospital General, Elche & Universidad Miguel Hernández, Alicante eHospital Rio Hortega, Valladolid fHospital Vall d'Hebron, Barcelona gHospital Universitario Puerta de Hierro & Puerta de Hierro Research Institute, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000269DOI Listing
July 2014
15 Reads
4 Citations
5.554 Impact Factor

[Hepatitis E: an emerging viral disease].

Med Clin (Barc) 2014 Jul 20;143(1):22-4. Epub 2014 Mar 20.

Servicio de Enfermedades Infecciosas, Hospital Carlos III, Madrid, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2014.01.021DOI Listing
July 2014
6 Reads
1.252 Impact Factor

Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.

Eur J Prev Cardiol 2014 Jun 20;21(6):739-48. Epub 2012 Jun 20.

Department of Internal Medicine, Hospital Clínico San Carlos, Madrid, Spain Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487312452964DOI Listing
June 2014
46 Reads
9 Citations
2.675 Impact Factor

Dolutegravir, abacavir and lamivudine as HIV therapy.

Expert Opin Pharmacother 2014 May;15(7):1051-7

Hospital Carlos III, Department of Infectious Diseases , Madrid , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.913023DOI Listing
May 2014
9 Reads
2 Citations
3.534 Impact Factor

A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.

Liver Int 2014 Apr 16;34(4):558-66. Epub 2013 Oct 16.

Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain; Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.12330DOI Listing
April 2014
3 Reads
4.850 Impact Factor

[Infections due to human immunodeficiency virus type 2 and human T-lymphotropic viruses in Spain].

Med Clin (Barc) 2014 Apr 6;142(7):323-6. Epub 2013 Sep 6.

Servicio de Enfermedades Infecciosas, Hospital Carlos III, Madrid, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2013.06.009DOI Listing
April 2014
39 Reads
1.252 Impact Factor

Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy.

J Infect 2014 Apr 22;68(4):372-7. Epub 2013 Nov 22.

Unit of Infectious Diseases, Instituto Maimonides de Investigación Biomedica de Córdoba (IMIBIC), Hospital Universitario Reina Sofia, Cordoba, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2013.11.009DOI Listing
April 2014
9 Reads
2 Citations
4.441 Impact Factor

Emerging antiretroviral drugs.

Expert Opin Pharmacother 2014 Feb 30;15(2):211-9. Epub 2013 Nov 30.

Hospital Carlos III, Department of Infectious Diseases, C/Sinesio Delgado 10, Madrid, 28029 , Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.863277DOI Listing
February 2014
13 Reads
7 Citations
3.534 Impact Factor

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection.

AIDS 2013 Nov;27(17):2715-24

aUnit of Infectious Diseases and Microbiology, Hospital Universitario de Valme bInstituto de Biomedicina de Sevilla (IBiS), Seville cImmunogenetics Unit, Faculty of Sciences, Universidad de Jaén, Jaen dUnit of Infectious Diseases, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba eDepartment of Infectious Diseases, Hospital Carlos III, Madrid fUnit of Infectious Diseases, Hospital Juan Ramón Jiménez. Huelva, Spain.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/aidsonline/2013/11130/Variation
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/01.aids.0000432459.36970.a9DOI Listing
November 2013
62 Reads
3 Citations
5.554 Impact Factor

Hepatitis C virus genotype 4 in Southern and Central Spain does not originate from recent foreign migration waves.

J Med Virol 2013 Oct 16;85(10):1734-40. Epub 2013 Jul 16.

Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.23657DOI Listing
October 2013
9 Reads
3 Citations
2.350 Impact Factor

Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.

Expert Opin Drug Saf 2013 Sep 4;12(5):697-707. Epub 2013 Jun 4.

Hospital Carlos III, Department of Infectious Diseases, C/Sinesio Delgado 10, Madrid, 28029, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2013.806480DOI Listing
September 2013
8 Reads
6 Citations
2.911 Impact Factor

Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.

AIDS 2013 Sep;27(14):2219-24

aDepartment of Infectious Diseases, Hospital Carlos III bHospital Conxo-CHUS, Santiago de Compostela cInibic-Complexo Hospitalario Universitario, A Coruña dCentro Sanitario Sandoval, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e328362fe42DOI Listing
September 2013
14 Reads
3 Citations
5.554 Impact Factor

Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.

Clin Infect Dis 2013 Aug 10;57(3):465-8. Epub 2013 Apr 10.

Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cit224DOI Listing
August 2013
4 Reads
12 Citations
8.890 Impact Factor

[Healthcare resources restrictions and human immunodeficiency virus infection].

Med Clin (Barc) 2013 Aug 26;141(3):114-5. Epub 2013 Mar 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2013.01.034DOI Listing
August 2013
7 Reads
1 Citation
1.252 Impact Factor

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response.

J Infect 2013 Jul 28;67(1):59-64. Epub 2013 Mar 28.

Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Avenida de Bellavista S/N, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2013.03.010DOI Listing
July 2013
4 Reads
3 Citations
4.441 Impact Factor

Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.

AIDS Rev 2012 Oct-Dec;14(4):223-30

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
June 2013
5 Reads
11 Citations
3.790 Impact Factor

Emerging viral infections‑-a potential threat for blood supply in the 21st century.

AIDS Rev 2012 Oct-Dec;14(4):279-89

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
June 2013
7 Reads
3 Citations
3.790 Impact Factor

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients.

J Antimicrob Chemother 2013 Apr 12;68(4):915-21. Epub 2012 Dec 12.

Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Avenida de Bellavista S/N, 41014 Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dks488DOI Listing
April 2013
15 Reads
5.313 Impact Factor

Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.

AIDS 2013 Apr;27(7):1129-34

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32835e063fDOI Listing
April 2013
7 Reads
9 Citations
5.554 Impact Factor

Cardiovascular disease risk in HIV infection and endothelial progenitor cells.

J Infect Dis 2012 Nov 22;206(9):1479-80; author reply 1480-1. Epub 2012 Aug 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jis518DOI Listing
November 2012
7 Reads
6.000 Impact Factor

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.

Retrovirology 2012 Aug 13;9:68. Epub 2012 Aug 13.

Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciones Científicas & Universidad Autónoma de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-4690-9-68DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468358PMC
August 2012
34 Reads
4 Citations
4.185 Impact Factor

Management of hepatitis C in HIV and/or HBV co-infected patients.

Best Pract Res Clin Gastroenterol 2012 Aug;26(4):517-30

Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, Madrid 28029, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2012.09.007DOI Listing
August 2012
4 Reads
6 Citations
3.480 Impact Factor

No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients.

Antiviral Res 2012 Aug 7;95(2):67-71. Epub 2012 Jun 7.

Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Instituto de Biomedicina de Sevilla, Avenida de Bellavista s/n, 41014 Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.antiviral.2012.05.016DOI Listing
August 2012
44 Reads
1 Citation
3.940 Impact Factor

Short communication high risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells.

AIDS Res Hum Retroviruses 2012 Jul 21;28(7):656-9. Epub 2011 Sep 21.

Infectious Disease Department, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2011.0152DOI Listing
July 2012
8 Reads
3 Citations
2.330 Impact Factor

A new era for hepatitis C-new diagnostics tools and new weapons.

Authors:
Vicente Soriano

ACS Med Chem Lett 2012 Jun 3;3(6):440-1. Epub 2012 May 3.

Department of Infectious Diseases, Hospital Carlos III , Calle Sinesio Delgado 10, Madrid 28029, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ml300098kDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025808PMC
June 2012
7 Reads
3.120 Impact Factor

Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting.

Ther Drug Monit 2012 Apr;34(2):232-5

Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0b013e31824aa50aDOI Listing
April 2012
10 Reads
5 Citations
2.380 Impact Factor

HIV and the Liver

Sherlock's Diseases of the Liver and Biliary System, 12th Edition

http://www.scopus.com/inward/record.url?eid=2-s2.0-80855166273&partnerID=MN8TOARS

View Article
2011
2 Reads

Host genetics.

Curr Opin HIV AIDS 2011 Nov;6(6):491-500

Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0b013e32834bca2dDOI Listing
November 2011
12 Reads
2 Citations
4.680 Impact Factor

[Human immunodeficiency virus infection and viral hepatitis].

Enferm Infecc Microbiol Clin 2011 Nov 5;29(9):691-701. Epub 2011 Oct 5.

Servicio de Enfermedades Infecciosas, Hospital Carlos III, Madrid, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eimc.2011.07.003DOI Listing
November 2011
6 Reads
2 Citations
1.881 Impact Factor

Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.

J Infect 2011 Nov 12;63(5):382-90. Epub 2011 Aug 12.

Laboratory of Molecular Epidemiology of Infectious Diseases, Centro Nacional de Microbiología, Instituto de Salud Carlos III (Campus Majadahonda), Carretera Majadahonda-Pozuelo, Km 2.2, 28220 Majadahonda, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinf.2011.08.006DOI Listing
November 2011
33 Reads
11 Citations
4.441 Impact Factor

[Preexposure prophylaxis in the prevention of HIV infection].

Med Clin (Barc) 2011 Oct 14;137(10):446-8. Epub 2011 Jun 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2011.04.017DOI Listing
October 2011
28 Reads
1.250 Impact Factor

High concordance between the position-specific scoring matrix and geno2pheno algorithms for genotypic interpretation of HIV-1 tropism: V3 length as the major cause of disagreement.

J Clin Microbiol 2011 Sep 6;49(9):3380-2. Epub 2011 Jul 6.

Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.00908-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165608PMC
September 2011
15 Reads
13 Citations
3.990 Impact Factor